iRhythm Holdings IRTC
NASDAQ IRTC
$121.43 -0.81 (-0.66%)
As of: Sep 9, 2026 · 12:14 PM EDT

iRhythm Holdings (IRTC) Restructuring Costs (2022 - 2026)

iRhythm Holdings' (IRTC) quarterly Restructuring Costs came in at $14.0 million in Q2 2026, up 25.93% quarter-over-quarter from $11.1 million in Q4 2023.

Analysis

iRhythm Holdings (IRTC) Restructuring Costs (2022 - 2026) Analysis & Trends

iRhythm Holdings (IRTC) has reported Restructuring Costs for 3 consecutive years, with $14.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Restructuring Costs changed N/A year-over-year to $14.0 million in Q2 2026; TTM through Jun 2026 was $25.0 million, a 125.93% increase from a year earlier, with the FY2024 full-year figure at $641000.0, down 94.21% from the prior year.
  • Restructuring Costs was $14.0 million for Q2 2026 at iRhythm Holdings, up from $11.1 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $26.6 million in Q1 2022 and troughed at $11.1 million in Q4 2023.
  • A 3-year average of $17.2 million and a median of $14.0 million in 2026 frame the typical range for Restructuring Costs.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 47.02 Bn 45.92 Bn 486.15 Mn
2 Labcorp Holdings 26.15 Bn 26.01 Bn 1.11 Bn
3 Quest Diagnostics 25.87 Bn 25.25 Bn 1.03 Bn
4 Guardant Health 21.79 Bn 20.74 Bn 219.03 Mn
5 Tempus AI 11.20 Bn 10.38 Bn 274.25 Mn
6 Caris Life Sciences 6.94 Bn 6.15 Bn 182.38 Mn
7 Sotera Health 5.24 Bn 4.88 Bn 177.96 Mn
8 BillionToOne 4.66 Bn 4.11 Bn 77.11 Mn
9 iRhythm Holdings 3.99 Bn 3.40 Bn 163.21 Mn
10 Adaptive Biotechnologies 3.90 Bn 3.55 Bn 51.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.95 Mn
Dec 31, 2023 11.08 Mn
Mar 31, 2022 26.61 Mn